V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196687 | 20125272 | 1.76 | 88.7 | Adjuvant (A) | 2017-04-06 | 2017-04-06 | CETUXIMAB | 02 | Y | CETUXIMAB | 100414678 |
| 20196696 | 20125273 | 1.59 | 79.4 | Curative (C) | 2017-07-13 | 2018-03-21 | CETUXIMAB | 02 | Y | CETUXIMAB | 100176835 |
| 20196699 | 20125274 | 1.76 | 81.4 | Palliative (P) | 2017-08-07 | 2018-12-01 | CETUXIMAB | N | N | CETUXIMAB | 100555387 |
| 20196700 | 20125275 | 1.63 | 95 | Curative (C) | 2020-01-24 | 2020-03-06 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100380639 |
| 20196704 | 20125276 | 1.83 | 60.2 | Palliative (P) | 2019-04-26 | 2019-05-14 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100989604 |
| 20196706 | 20125277 | 1.61 | 73.8 | Neo-adjuvant (N) | 2017-02-28 | 2019-05-23 | Cetuximab 14 day | N | Y | CETUXIMAB | 101799629 |
| 20196707 | 20125278 | 1.88 | null | Palliative (P) | 2019-05-30 | 2019-06-12 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 100432562 |
| 20196713 | 20125279 | 1.76 | 57.7 | Palliative (P) | 2019-10-04 | 2019-10-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100054584 |
| 20196717 | 20125280 | 1.75 | 83 | Neo-adjuvant (N) | 2018-06-13 | 2018-06-24 | Trastuzumab | N | N | TRASTUZUMAB | 100897046 |
| 20196719 | 20125281 | 1.84 | 63.1 | Neo-adjuvant (N) | 2019-09-06 | 2019-11-11 | Cetuximab 14 day | 02 | null | TRASTUZUMAB | 101359250 |
| 20196721 | 20125282 | 1.64 | 91 | Palliative (P) | 2019-04-22 | 2019-05-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 100529082 |
| 20196722 | 20125283 | null | null | Neo-adjuvant (N) | 2019-01-18 | 2019-01-18 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100197137 |
| 20196726 | 20125284 | 1.75 | 88.7 | Curative (C) | null | null | CETUXIMAB | 02 | N | CETUXIMAB | 101744862 |
| 20196729 | 20125285 | 1.81 | 80.4 | null | 2018-09-28 | 2018-10-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101697044 |
| 20196735 | 20125286 | 1.61 | 73.8 | Neo-adjuvant (N) | 2020-05-22 | 2020-09-05 | Trastuzumab | N | N | TRASTUZUMAB | 101015016 |
| 20196736 | 20125287 | 1.74 | 49.8 | Palliative (P) | 2019-03-01 | 2019-03-01 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 101237654 |
| 20196738 | 20125288 | 0 | 71 | null | 2019-03-09 | 2019-03-10 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101090721 |
| 20196746 | 20125289 | 1.76 | 80.6 | Neo-adjuvant (N) | 2019-04-02 | 2019-04-17 | Trastuzumab 21 day loading dose | N | N | TRASTUZUMAB | 100658318 |
| 20196749 | 20125290 | 1.76 | 75 | Neo-adjuvant (N) | 2015-12-10 | 2016-02-24 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101825605 |
| 20196755 | 20125291 | 1.73 | 88.5 | Neo-adjuvant (N) | 2017-12-26 | 2018-02-06 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101148845 |
| 20196756 | 20125292 | 1.66 | 86.3 | Adjuvant (A) | 2016-09-22 | 2016-10-09 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101727882 |
| 20196759 | 20125293 | 1.63 | 65 | Neo-adjuvant (N) | null | 2019-04-18 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100480317 |
| 20196780 | 20125294 | 1.89 | 93.9 | Curative (C) | 2018-08-13 | 2018-08-15 | CETUXIMAB | 02 | N | CETUXIMAB | 100208914 |
| 20196781 | 20125295 | 1.58 | 95.5 | Palliative (P) | 2018-06-05 | 2018-06-18 | Trastuzumab Subcutaneous | null | Y | TRASTUZUMAB | 100832954 |
| 20196788 | 20125296 | 1.74 | 46.6 | Curative (C) | 2021-05-16 | 2021-05-16 | CETUXIMAB | 02 | N | CETUXIMAB | 100678499 |
| 20196790 | 20125297 | 1.8 | 88.2 | Palliative (P) | 2017-10-28 | 2017-10-28 | Trastuzumab | 99 | null | TRASTUZUMAB | 101810227 |
| 20196791 | 20125298 | 1.64 | 63.2 | 03 | 2018-05-13 | 2018-05-28 | Trastuzumab | 02 | N | TRASTUZUMAB | 101076890 |
| 20196793 | 20125299 | 1.8 | 50.4 | Palliative (P) | 2016-09-03 | 2016-09-10 | Trastuzumab | 02 | null | TRASTUZUMAB | 101797851 |
| 20196797 | 20125300 | 1.51 | 77.8 | Neo-adjuvant (N) | 2016-12-12 | 2016-12-12 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100771656 |
| 20196799 | 20125301 | 1.76 | 96.88 | Neo-adjuvant (N) | 2017-03-20 | 2017-08-03 | CETUXIMAB | 02 | N | CETUXIMAB | 100292189 |
| 20196803 | 20125302 | 1.51 | 99.2 | Palliative (P) | 2018-05-25 | 2019-01-26 | Trastuzumab | 02 | Y | TRASTUZUMAB | 101105638 |
| 20196804 | 20125303 | 1.61 | 58.7 | Curative (C) | 2017-06-13 | 2017-10-11 | Trastuzumab 21 day maintenance | null | Y | TRASTUZUMAB | 101407821 |
| 20196811 | 20125304 | 1.85 | 71.6 | Palliative (P) | 2017-06-12 | 2017-06-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101497751 |
| 20196814 | 20125305 | 1.73 | 102.3 | null | 2016-10-18 | 2016-11-13 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101492854 |
| 20196819 | 20125306 | 1.73 | 45.25 | Palliative (P) | 2018-09-30 | 2018-10-12 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101230729 |
| 20196822 | 20125307 | 1.74 | 70 | Curative (C) | 2019-11-10 | 2019-11-10 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101636387 |
| 20196827 | 20125308 | 1.61 | 80 | null | 2017-08-11 | 2017-08-11 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101835550 |
| 20196829 | 20125309 | 1.72 | 53 | Curative (C) | 2018-05-04 | 2018-05-04 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100772410 |
| 20196830 | 20125310 | 1.8 | 60.05 | null | 2016-06-06 | 2017-02-02 | CETUXIMAB | 02 | N | CETUXIMAB | 100142282 |
| 20196831 | 20125311 | 1.59 | 63.8 | Neo-adjuvant (N) | 2016-10-25 | 2016-11-25 | Capecitabine + Cisplatin + RT | 99 | Y | CAPECITABINE + CISPLATIN | 101302067 |
| 20196833 | 20125312 | 1.8 | 69 | Palliative (P) | 2017-04-05 | 2017-04-26 | Trastuzumab | 02 | null | TRASTUZUMAB | 101211917 |
| 20196836 | 20125313 | 1.56 | 81 | Curative (C) | 2018-09-16 | 2018-09-23 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 101343172 |
| 20196841 | 20125314 | 1.52 | 56.7 | Curative (C) | 2018-12-31 | 2019-01-13 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 100099547 |
| 20196842 | 20125315 | 1.62 | 69 | Curative (C) | 2019-01-22 | 2019-03-17 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100711354 |
| 20196843 | 20125316 | 1.73 | 82 | Curative (C) | 2019-04-12 | 2019-05-08 | CETUXIMAB | 02 | N | CETUXIMAB | 100619600 |
| 20196844 | 20125317 | 1.74 | 50.4 | null | 2020-01-02 | 2020-01-09 | CETUXIMAB | 02 | Y | TRASTUZUMAB | 100677715 |
| 20196847 | 20125318 | 1.63 | 88.4 | Curative (C) | 2016-09-23 | 2016-11-18 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101506116 |
| 20196852 | 20125319 | 1.72 | 52 | Neo-adjuvant (N) | 2016-03-16 | 2016-04-26 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101036041 |
| 20196853 | 20125320 | 1.58 | 44 | null | 2017-08-25 | 2017-09-13 | CETUXIMAB | null | null | CETUXIMAB | 101248293 |
| 20196859 | 20125321 | 1.55 | 62 | Curative (C) | 2018-06-06 | 2020-09-02 | Trastuzumab | 02 | null | TRASTUZUMAB | 100246141 |